Affect Therapeutics Inc

Treatment

Treatment Setting

• Outpatient
• Telemedicine
• Intensive outpatient treatment (IOP)
• Outpatient (methadone/buprenorphine or naltrexone treatment)
• Regular outpatient treatment

Treatment Approaches

• Incentive-based therapy
• Matrix Model program
• Motivational interviewing
• Relapse prevention support
• Substance use counseling

Additional Support and Services

• Case management support
• Social skills training

Counseling and Education

• General health education services
• Group therapy
• Hepatitis education and support
• HIV/AIDS education and support
• One-on-one counseling
• Substance use education
• Tobacco and vaping cessation counseling

Transition Support

• Discharge and next steps planning
• Ongoing recovery care
• Overdose prevention and naloxone education
• Post-discharge follow-up

Testing & Pre-Treatment

• Breathalyzer testing for alcohol
• Community outreach and support
• Comprehensive health checkup
• Mental health screening
• Oral fluid testing for drugs or alcohol
• Substance use assessment
• Temporary support for clients
• Tobacco use assessment
• Tuberculosis screening
• Urine testing for drugs or alcohol
• Substance use screening

Medication-Based Treatments

• Buprenorphine (any)
• Naltrexone (any)
• Acamprosate (Campral)
• Buprenorphine with naloxone
• Buprenorphine without naloxone
• Clonidine
• Naltrexone (oral)
• Non-nicotine smoking/tobacco cessation

Amenities and Experiences

Policies

• Smoking allowed in designated areas
• Vaping allowed in designated areas

Ownership Type

• For-profit